 Robert Cina
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendicitis | 5 | 2023 | 150 | 1.860 |
Why?
| | Analgesics, Opioid | 10 | 2023 | 1154 | 1.790 |
Why?
| | Herniorrhaphy | 7 | 2021 | 76 | 1.370 |
Why?
| | Tonsillectomy | 4 | 2021 | 105 | 1.250 |
Why?
| | Inappropriate Prescribing | 2 | 2019 | 66 | 1.060 |
Why?
| | Appendectomy | 6 | 2023 | 90 | 1.030 |
Why?
| | Hernia, Inguinal | 3 | 2023 | 43 | 1.020 |
Why?
| | Specialties, Surgical | 2 | 2019 | 82 | 1.000 |
Why?
| | Practice Patterns, Physicians' | 7 | 2023 | 1372 | 0.960 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 605 | 0.940 |
Why?
| | Surgical Wound Infection | 7 | 2025 | 329 | 0.810 |
Why?
| | Intestinal Perforation | 1 | 2022 | 46 | 0.700 |
Why?
| | Peritonitis | 1 | 2022 | 83 | 0.680 |
Why?
| | Teratoma | 1 | 2021 | 124 | 0.630 |
Why?
| | Burns | 3 | 2020 | 374 | 0.590 |
Why?
| | Autistic Disorder | 1 | 2022 | 219 | 0.580 |
Why?
| | Child | 26 | 2026 | 22738 | 0.580 |
Why?
| | Surgeons | 2 | 2019 | 340 | 0.520 |
Why?
| | Antibiotic Prophylaxis | 4 | 2025 | 134 | 0.490 |
Why?
| | Retrospective Studies | 20 | 2025 | 17322 | 0.450 |
Why?
| | Ovarian Neoplasms | 1 | 2021 | 595 | 0.450 |
Why?
| | Enterobiasis | 1 | 2013 | 1 | 0.400 |
Why?
| | Enterobius | 1 | 2013 | 2 | 0.400 |
Why?
| | Cardiac Valve Annuloplasty | 1 | 2013 | 3 | 0.390 |
Why?
| | Appendix | 1 | 2013 | 31 | 0.390 |
Why?
| | Heart Injuries | 1 | 2013 | 42 | 0.380 |
Why?
| | Drug Prescriptions | 3 | 2020 | 288 | 0.380 |
Why?
| | Surgical Wound | 2 | 2023 | 27 | 0.370 |
Why?
| | Quality Improvement | 2 | 2023 | 1296 | 0.370 |
Why?
| | Multiple Trauma | 1 | 2013 | 121 | 0.350 |
Why?
| | Infant | 12 | 2025 | 10089 | 0.340 |
Why?
| | Cardiopulmonary Bypass | 1 | 2013 | 219 | 0.330 |
Why?
| | Wounds, Nonpenetrating | 2 | 2013 | 321 | 0.320 |
Why?
| | Hernia, Umbilical | 2 | 2021 | 21 | 0.310 |
Why?
| | Anti-Infective Agents | 2 | 2023 | 232 | 0.310 |
Why?
| | Hospitalization | 1 | 2020 | 2460 | 0.300 |
Why?
| | Humans | 39 | 2026 | 145750 | 0.290 |
Why?
| | Pediatrics | 2 | 2017 | 1124 | 0.290 |
Why?
| | Clinical Competence | 1 | 2017 | 1247 | 0.280 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2383 | 0.260 |
Why?
| | Cell Lineage | 2 | 2006 | 378 | 0.250 |
Why?
| | Digestive System Surgical Procedures | 2 | 2026 | 112 | 0.240 |
Why?
| | Chimerism | 1 | 2006 | 35 | 0.240 |
Why?
| | Adolescent | 13 | 2026 | 22569 | 0.230 |
Why?
| | Child, Preschool | 11 | 2025 | 11866 | 0.230 |
Why?
| | Funnel Chest | 1 | 2025 | 29 | 0.220 |
Why?
| | Postoperative Complications | 2 | 2023 | 2977 | 0.220 |
Why?
| | Cholelithiasis | 1 | 2025 | 36 | 0.220 |
Why?
| | Acute Disease | 2 | 2021 | 1036 | 0.220 |
Why?
| | Laparoscopy | 3 | 2020 | 481 | 0.220 |
Why?
| | Cholecystectomy | 1 | 2025 | 61 | 0.210 |
Why?
| | Elective Surgical Procedures | 1 | 2026 | 203 | 0.210 |
Why?
| | Incidence | 3 | 2022 | 2933 | 0.210 |
Why?
| | Liver | 1 | 2013 | 1899 | 0.210 |
Why?
| | Colorectal Neoplasms | 2 | 2023 | 868 | 0.210 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2006 | 699 | 0.190 |
Why?
| | Postoperative Care | 1 | 2025 | 286 | 0.190 |
Why?
| | Narcotics | 1 | 2023 | 58 | 0.190 |
Why?
| | Male | 19 | 2026 | 72992 | 0.190 |
Why?
| | Esophageal Atresia | 1 | 2022 | 32 | 0.180 |
Why?
| | Tracheoesophageal Fistula | 1 | 2022 | 40 | 0.180 |
Why?
| | Patient Readmission | 3 | 2025 | 772 | 0.180 |
Why?
| | Female | 19 | 2026 | 79025 | 0.180 |
Why?
| | Transplantation Tolerance | 3 | 2014 | 39 | 0.180 |
Why?
| | Tracheostomy | 1 | 2023 | 142 | 0.170 |
Why?
| | Personal Satisfaction | 1 | 2023 | 219 | 0.170 |
Why?
| | Vomiting | 1 | 2021 | 131 | 0.160 |
Why?
| | Constipation | 1 | 2022 | 98 | 0.160 |
Why?
| | Length of Stay | 3 | 2026 | 1350 | 0.160 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2001 | 252 | 0.150 |
Why?
| | Anti-Bacterial Agents | 3 | 2025 | 1925 | 0.150 |
Why?
| | Myocardial Ischemia | 1 | 2001 | 285 | 0.140 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 237 | 0.140 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2020 | 128 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 79 | 0.140 |
Why?
| | Perioperative Care | 1 | 2001 | 231 | 0.140 |
Why?
| | Kidney Transplantation | 3 | 2014 | 712 | 0.140 |
Why?
| | Major Histocompatibility Complex | 4 | 2006 | 233 | 0.130 |
Why?
| | Biomedical Technology | 1 | 2018 | 50 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2001 | 271 | 0.130 |
Why?
| | Swine, Miniature | 6 | 2014 | 89 | 0.130 |
Why?
| | Transplantation Chimera | 3 | 2006 | 57 | 0.130 |
Why?
| | Pandemics | 2 | 2022 | 1711 | 0.120 |
Why?
| | Swine | 6 | 2014 | 826 | 0.120 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 558 | 0.110 |
Why?
| | Mobile Applications | 1 | 2018 | 199 | 0.110 |
Why?
| | United States | 5 | 2026 | 16122 | 0.110 |
Why?
| | Home Care Services | 1 | 2018 | 284 | 0.110 |
Why?
| | Cyclosporine | 2 | 2014 | 256 | 0.110 |
Why?
| | Parents | 1 | 2023 | 1404 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2967 | 0.100 |
Why?
| | Bone Marrow Transplantation | 2 | 2005 | 298 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2018 | 479 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2017 | 554 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 610 | 0.100 |
Why?
| | Abdomen, Acute | 1 | 2013 | 21 | 0.100 |
Why?
| | Tricuspid Valve | 1 | 2013 | 43 | 0.100 |
Why?
| | Graft vs Host Disease | 2 | 2006 | 279 | 0.090 |
Why?
| | Cohort Studies | 4 | 2025 | 6032 | 0.090 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 54 | 0.090 |
Why?
| | Machine Learning | 1 | 2018 | 587 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2014 | 364 | 0.090 |
Why?
| | Colony-Forming Units Assay | 3 | 2006 | 95 | 0.090 |
Why?
| | Graft Rejection | 2 | 2014 | 521 | 0.090 |
Why?
| | Occlusive Dressings | 1 | 2011 | 7 | 0.090 |
Why?
| | beta-Glucans | 1 | 2011 | 16 | 0.090 |
Why?
| | Critical Pathways | 1 | 2013 | 109 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2020 | 1202 | 0.090 |
Why?
| | Pylorus | 1 | 2011 | 17 | 0.080 |
Why?
| | Coated Materials, Biocompatible | 1 | 2011 | 65 | 0.080 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2011 | 56 | 0.080 |
Why?
| | Transplantation, Homologous | 3 | 2006 | 419 | 0.080 |
Why?
| | Infant, Newborn | 6 | 2021 | 6464 | 0.080 |
Why?
| | Thoracic Injuries | 1 | 2011 | 71 | 0.080 |
Why?
| | Risk Assessment | 2 | 2018 | 3752 | 0.080 |
Why?
| | Aftercare | 2 | 2023 | 222 | 0.080 |
Why?
| | Algorithms | 1 | 2018 | 1850 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1582 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2014 | 426 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2025 | 11793 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1512 | 0.070 |
Why?
| | Collagen | 1 | 2011 | 457 | 0.070 |
Why?
| | Telemedicine | 1 | 2018 | 963 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2013 | 587 | 0.070 |
Why?
| | Graft Survival | 3 | 2006 | 519 | 0.070 |
Why?
| | Thymus Gland | 2 | 2006 | 312 | 0.070 |
Why?
| | Granulocyte Precursor Cells | 1 | 2006 | 9 | 0.060 |
Why?
| | Haploidy | 1 | 2006 | 28 | 0.060 |
Why?
| | Platelet Count | 1 | 2006 | 94 | 0.060 |
Why?
| | Lymphocyte Count | 1 | 2006 | 165 | 0.060 |
Why?
| | Internship and Residency | 1 | 2017 | 1269 | 0.060 |
Why?
| | Gastroesophageal Reflux | 2 | 1999 | 237 | 0.060 |
Why?
| | Animals | 11 | 2014 | 38100 | 0.060 |
Why?
| | Patient Discharge | 2 | 2023 | 995 | 0.060 |
Why?
| | Cefazolin | 1 | 2025 | 22 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2006 | 191 | 0.050 |
Why?
| | Clinical Protocols | 1 | 2026 | 280 | 0.050 |
Why?
| | Cell Transplantation | 1 | 2004 | 39 | 0.050 |
Why?
| | Lung Diseases | 1 | 2011 | 782 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2005 | 102 | 0.050 |
Why?
| | Transplantation | 1 | 2004 | 33 | 0.050 |
Why?
| | Recurrence | 2 | 2020 | 1139 | 0.050 |
Why?
| | Lymphoproliferative Disorders | 1 | 2004 | 59 | 0.050 |
Why?
| | Risk Factors | 4 | 2022 | 10916 | 0.050 |
Why?
| | Spleen | 1 | 2005 | 508 | 0.050 |
Why?
| | Endogenous Retroviruses | 1 | 2004 | 37 | 0.050 |
Why?
| | Prescriptions | 1 | 2023 | 74 | 0.050 |
Why?
| | Organ Transplantation | 1 | 2006 | 253 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 377 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2005 | 385 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2770 | 0.050 |
Why?
| | Wound Healing | 2 | 2018 | 355 | 0.050 |
Why?
| | Reoperation | 1 | 2025 | 637 | 0.050 |
Why?
| | Cholecystokinin | 2 | 1998 | 15 | 0.040 |
Why?
| | Prospective Studies | 4 | 2026 | 8075 | 0.040 |
Why?
| | South Carolina | 1 | 2021 | 47 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 191 | 0.040 |
Why?
| | Program Development | 1 | 2023 | 368 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5428 | 0.040 |
Why?
| | Immunosuppressive Agents | 3 | 2014 | 838 | 0.040 |
Why?
| | Medicaid | 1 | 2023 | 467 | 0.040 |
Why?
| | Acetonitriles | 1 | 1998 | 12 | 0.040 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 60 | 0.030 |
Why?
| | Polymerase Chain Reaction | 3 | 2006 | 1043 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1998 | 165 | 0.030 |
Why?
| | Videoconferencing | 1 | 2018 | 65 | 0.030 |
Why?
| | Solvents | 1 | 1998 | 112 | 0.030 |
Why?
| | Ultrasonography | 2 | 2013 | 788 | 0.030 |
Why?
| | Area Under Curve | 1 | 2018 | 332 | 0.030 |
Why?
| | Flow Cytometry | 3 | 2006 | 1165 | 0.030 |
Why?
| | Receptors, Cholecystokinin | 1 | 1997 | 9 | 0.030 |
Why?
| | Benzodiazepinones | 1 | 1997 | 18 | 0.030 |
Why?
| | ROC Curve | 1 | 2018 | 618 | 0.030 |
Why?
| | Infant, Premature | 1 | 2020 | 620 | 0.030 |
Why?
| | Text Messaging | 1 | 2018 | 182 | 0.030 |
Why?
| | Dietary Fats | 1 | 1997 | 308 | 0.030 |
Why?
| | Needles | 1 | 2014 | 63 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2001 | 1751 | 0.030 |
Why?
| | Registries | 1 | 2023 | 2410 | 0.030 |
Why?
| | Operative Time | 1 | 2014 | 181 | 0.020 |
Why?
| | Quality of Life | 1 | 2026 | 3210 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2139 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2013 | 142 | 0.020 |
Why?
| | Delayed Diagnosis | 1 | 2013 | 100 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2014 | 202 | 0.020 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 134 | 0.020 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 195 | 0.020 |
Why?
| | Diagnostic Errors | 1 | 2013 | 178 | 0.020 |
Why?
| | Polyhydramnios | 1 | 2011 | 17 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1270 | 0.020 |
Why?
| | Pregnancy | 3 | 2011 | 7215 | 0.020 |
Why?
| | Emergency Medicine | 1 | 2013 | 282 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 1997 | 928 | 0.020 |
Why?
| | Patient Care Team | 1 | 2013 | 697 | 0.020 |
Why?
| | T-Lymphocytes | 2 | 2005 | 1997 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2005 | 123 | 0.010 |
Why?
| | Splenectomy | 1 | 2005 | 61 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 2005 | 49 | 0.010 |
Why?
| | Sus scrofa | 1 | 2005 | 65 | 0.010 |
Why?
| | Isoantibodies | 1 | 2005 | 57 | 0.010 |
Why?
| | Hematologic Diseases | 1 | 2005 | 66 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 2005 | 132 | 0.010 |
Why?
| | Proviruses | 1 | 2004 | 16 | 0.010 |
Why?
| | Monitoring, Physiologic | 1 | 2005 | 289 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 2004 | 170 | 0.010 |
Why?
| | Uterus | 1 | 2005 | 228 | 0.010 |
Why?
| | Models, Animal | 1 | 2005 | 393 | 0.010 |
Why?
| | Prenatal Diagnosis | 1 | 2005 | 196 | 0.010 |
Why?
| | Creatinine | 1 | 2005 | 515 | 0.010 |
Why?
| | Fetal Diseases | 1 | 2005 | 194 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2005 | 509 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 328 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 205 | 0.010 |
Why?
| | Haplotypes | 1 | 2004 | 500 | 0.010 |
Why?
| | Blood Transfusion | 1 | 2005 | 409 | 0.010 |
Why?
| | Galactosidases | 1 | 1981 | 2 | 0.010 |
Why?
| | Antigen-Antibody Reactions | 1 | 1981 | 49 | 0.010 |
Why?
| | Gestational Age | 1 | 2005 | 989 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1981 | 76 | 0.010 |
Why?
| | Virus Replication | 1 | 2004 | 521 | 0.010 |
Why?
| | RNA, Viral | 1 | 2004 | 692 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2004 | 872 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1498 | 0.010 |
Why?
| | Manometry | 1 | 1997 | 98 | 0.010 |
Why?
| | Devazepide | 1 | 1997 | 4 | 0.010 |
Why?
| | Nitrosamines | 1 | 1997 | 9 | 0.010 |
Why?
| | Deglutition Disorders | 1 | 1999 | 154 | 0.010 |
Why?
| | Mesocricetus | 1 | 1997 | 52 | 0.010 |
Why?
| | Cricetinae | 1 | 1997 | 305 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 244 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1997 | 532 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4151 | 0.010 |
Why?
| | Carcinogens | 1 | 1997 | 123 | 0.010 |
Why?
| | Pancreatic Ducts | 1 | 1997 | 82 | 0.010 |
Why?
| | Organ Size | 1 | 1997 | 461 | 0.010 |
Why?
| | Endoscopy | 1 | 1997 | 317 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 1999 | 712 | 0.010 |
Why?
| | Pancreas | 1 | 1997 | 341 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4569 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 2000 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 7133 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 998 | 0.010 |
Why?
| | Decision Making | 1 | 1997 | 981 | 0.000 |
Why?
| | Hybrid Cells | 1 | 1981 | 49 | 0.000 |
Why?
| | Antibody Specificity | 1 | 1981 | 179 | 0.000 |
Why?
| | Clone Cells | 1 | 1981 | 263 | 0.000 |
Why?
| | Structure-Activity Relationship | 1 | 1981 | 563 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1981 | 762 | 0.000 |
Why?
| | Protein Conformation | 1 | 1981 | 938 | 0.000 |
Why?
| | Escherichia coli | 1 | 1981 | 835 | 0.000 |
Why?
| | Middle Aged | 1 | 1999 | 36297 | 0.000 |
Why?
| | Mutation | 1 | 1981 | 4090 | 0.000 |
Why?
| | Mice | 1 | 1981 | 18357 | 0.000 |
Why?
|
|
Cina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|